| 1 |
Chakrabarti R., Kapse B. , Mukherjee G, Soluble immune checkpoint molecules: Serum markers for cancer diagnosis and prognosis, Cancer reports, 2019 |
| 2 |
Katakowski JA, Mukherjee G, Wilner SE, Maier K, Harrison MT, DiLorenzo TP, Levy M, and Palliser D, Delivery of siRNAs to dendritic cells using DEC205-targeted lipid nanoparticles to inhibit immune responses, Mol. Ther, 2016 |
| 3 |
Babad J, Mukherjee G, Follenzi A, Ali R, Shultz L, Santamaria P, Yang O, Roep B, Goldstein H, Greiner D, DiLorenzo TP, Generation of ? cell-specific human T cells by lentiviral transduction and their survival in immunodeficient HLA-transgenic mice, Clin. Exp. Immunol, 179, 2015 |
| 4 |
Chaparro RJ, Schloss C, Smith C, Bando CD, Glucagon-reactive islet infiltrating CD8 T cells in NOD mice, Immunology, 144, 2015 |
| 5 |
Mukherjee G, Geliebter A, Babad J, Santamaria P, Serreze DV, Freeman GJ, Tarbell KV, Sharpe A, Dilorenzo TP, DEC-205-mediated antigen targeting to steady-state dendritic cells induces deletion of diabetogenic CD8+ T cells independently of PD-1 and PD-L1, Int. Immunol, 2015 |
| 6 |
Prakash RK, Samanta D, McPhee CG, Kay TWH, Almo SC, DiLorenzo TP, Serreze DV, Compensatory mechanisms allow undersized anchor-deficient Class I MHC ligands to mediate pathogenic autoreactive T-cell responses, J Immunol, 193, 2014 |
| 7 |
Antal Z, Baker JC, Smith C, Jarchum I, Babad J, Mukherjee G, Yang Y, Sidney J, Sette A, Santamaria P, DiLorenzo TP., HLA-transgenic nonobese diabetic mouse models of type 1 diabetes identify the insulin C-peptide as a rich source of CD8+ T cell epitopes., J Immunol, 188, 2012 |
| 8 |
Chakraborty DC, Mukherjee G, Banerjee P, Banerjee KK, Biswas T., Hemolysin induces Toll-like receptor (TLR)-independent apoptosis and multiple TLR-associated parallel activation of macrophages, J. Biol. Chem, 286, 2011 |
| 9 |
Samanta D*, Mukherjee G*, Ramagopal UA, Chaparro RJ, Nathenson SG, DiLorenzo TP, Almo SC, Structural and functional characterization of a single-chain peptide-MHC molecule that modulates both naive and activated CD8+ T cells, Proc. Natl. Acad. Sci. U S A, 108, 2011 |
| 10 |
Mukherjee G, Dilorenzo TP, The immunotherapeutic potential of dendritic cells in type 1 diabetes., Clin. Exp. Immunol, 161, 2010 |
